Alcon Prepares for Quarterly Report with Mixed Financial Projections
Alcon Inc. (NYSE:ALC), a leader in the eye care industry, is scheduled to release its financial results for the quarter ending September 2025 on November 11, 2025. The company anticipates a decrease in earnings per share but projects an increase in overall revenue.
For the quarter, Alcon forecasts an earnings per share (EPS) of $0.77, which represents a 4.9% decline compared to the same period in the previous year. However, revenue is expected to grow by 6.5% year-over-year, reaching an estimated $2.59 billion. This growth suggests effective market expansion and product line enhancements.
The company's valuation metrics show a high market valuation, with a price-to-earnings (P/E) ratio of 34.33. This suggests investor confidence in its earnings and sales generation capabilities. The price-to-sales ratio stands at approximately 3.67, and the enterprise value to sales ratio is about 4.05.
Alcon maintains a strong liquidity position, evidenced by a debt-to-equity ratio of 0.24 and a current ratio of 2.60. These figures indicate a manageable debt level and a solid capacity to cover short-term liabilities. The company's earnings yield is approximately 2.91%. For further details, see Alcon's financial health.
Alcon competes in the eye care sector with firms such as Johnson & Johnson Vision and Bausch + Lomb. More information about the company's background can be found in its history and ownership and its mission and vision. An overview for potential investors is also available at the investor profile.
Alcon Inc. (ALC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.